elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58407688-F3D09B7F-E7B3-4D3F-8DB7-D3B04B0E5A67
Q58407688-F3D09B7F-E7B3-4D3F-8DB7-D3B04B0E5A67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58407688-F3D09B7F-E7B3-4D3F-8DB7-D3B04B0E5A67
Anti-LAG-3 or Urelumab Alone and in Combination With Nivolumab in Treating Patients With Recurrent Glioblastoma
P3098
Q58407688-F3D09B7F-E7B3-4D3F-8DB7-D3B04B0E5A67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58407688-F3D09B7F-E7B3-4D3F-8DB7-D3B04B0E5A67
rank
NormalRank
type
BestRank
Statement
P3098
NCT02658981
http://www.w3.org/2001/XMLSchema#string